Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (801-810 of 933) with videos related to

Pageof 94
Sort By:
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|March 15, 2017
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described EntityAbbas Agaimy, Arndt Hartmann, Cristina R Antonescu, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
Nature Communications|January 22, 2019
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glandsFlorian Haller, Matthias Bieg, Rainer Will, et al.
Virchows Archiv : an International Journal of Pathology|October 4, 2025
Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 casesAnkur R Sangoi, Anandi Lobo, Ankit Tiwari, et al.
Cell Reports|December 14, 2022
The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress responseHarald Schuhwerk, Julia Kleemann, Pooja Gupta, et al.
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Pageof 94

Showing results (801-810 of 933) with videos related to

Sort By:
Pageof 94
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|March 15, 2017
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described EntityAbbas Agaimy, Arndt Hartmann, Cristina R Antonescu, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
Nature Communications|January 22, 2019
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glandsFlorian Haller, Matthias Bieg, Rainer Will, et al.
Virchows Archiv : an International Journal of Pathology|October 4, 2025
Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 casesAnkur R Sangoi, Anandi Lobo, Ankit Tiwari, et al.
Cell Reports|December 14, 2022
The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress responseHarald Schuhwerk, Julia Kleemann, Pooja Gupta, et al.
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Pageof 94